The Prevalence of Hepatitis C Virus (HCV) Infection and Genotypes in Patients with Hemophilia and Other Blood Coagulopathies in Mashhad, Iran
Archives of Medical Laboratory Sciences,
Vol. 7 (2021),
13 March 2021
,
Page 1-7 (e9)
https://doi.org/10.22037/amls.v7.33968
Abstract
Background and Aim: Patients with blood coagulopathies treated with multiple transfusions have a high risk to acquire some viral infections such as hepatitis C. This research was aimed to identify hepatitis C virus (HCV) infection prevalence, and the viral genotypes among patients with hemophilia and other inherited coagulopathies in Mashhad, Iran.
Methods: Medical records of 760 patients with inherited coagulopathies including hemophilia were reviewed in Sarvar Clinic of Mashhad. Plasma samples were subjected to detect antibodies against HCV (anti-HCV) by enzyme-linked immunosorbent assay. HCV RNA and genotypes were determined by a real-time polymerase chain reaction (PCR) method.
Results: Totally 128 individuals (16.8%) including patients with hemophilia (n=116) and individuals with other coagulopathies (n=12) were found to be seropositive for anti-HCV. They comprised 122 men and six women with a mean age of 31.6 ± 10.5 years. The PCR results were available for 118 patients, of whom 86 individuals (72.9%) were found to have detectable HCV RNA in their serum. The most frequent genotypes were 1a and 3a (49.1% and 35.8%, respectively). HCV genotypes were not significantly correlated with the patients’ age (p=0.477) as well as with the serum levels of alanine aminotransferase (p=0.655) and aspartate aminotransferase (p=0.332).
Conclusion: The patients with blood coagulation disorders had a greater prevalence of HCV infection in comparison with the general population in our region. The most common subgenotypes of HCV were 1a, and 3a, respectively. These results could assist professionals to choose more efficient approaches for the management of their patients.
*Corresponding Author: Mohammad Reza Hedayati-Moghaddam; Email: drhedayati@acecr.ac.ir
Please cite this article as: Badiei Z, Ahmadi-Ghezeldasht S, Sima HR, Habibi M, Khamooshi M, Azimi A, Hedayati-Moghaddam MR. The Prevalence of Hepatitis C Virus (HCV) Infection and Genotypes in Patients with Hemophilia and Other Blood Coagulopathies in Mashhad, Iran. Arch Med Lab Sci. 2021;7:1-7 (e9). https://doi.org/10.22037/amls.v7.33968
- Blood Coagulation Disorders
- Genotype
- HCV Infection
- Iran
- Prevalence
How to Cite
References
World Health Organization. Global hepatitis report 2017. Geneva: World Health Organization; 2017.
Mirminachi B, Mohammadi Z, Merat S, Neishabouri A, Sharifi AH, Alavian SH, et al. Update on the prevalence of hepatitis C virus infection among Iranian general population: A systematic review and meta-analysis. Hepatitis Monthly. 2017;17(2):e42291.
Khodabandehloo M, Roshani D, Sayehmiri K. Prevalence and trend of hepatitis C virus infection among blood donors in Iran: A systematic review and meta-analysis. Journal of Research in Medical Sciences. 2013;18(8):674-82.
Mahmud S, Akbarzadeh V, Abu-Raddad LJ. The epidemiology of hepatitis C virus in Iran: Systematic review and meta-analyses. Scientific Reports. 2018;8(1):150.
World Health Organization. Guidelines on hepatitis B and C testing. Geneva: World Health Organization; 2017 Licence: CC BY-NC-SA 3.0 IGO.
Chaabna K, Cheema S, Abraham A, Alrouh H, Lowenfels AB, Maisonneuve P, et al. Systematic overview of hepatitis C infection in the Middle East and North Africa. World Journal of Gastroenterology. 2018;24(27):3038-54.
Smith DB, Bukh J, Kuiken C, Muerhoff AS, Rice CM, Stapleton JT, et al. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology. 2014;59(1):318-27.
Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. Journal of Hepatology. 2014;61(1 Suppl):S45-57.
Petruzziello A, Marigliano S, Loquercio G, Cozzolino A, Cacciapuoti C. Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes. World Journal of Gastroenterology. 2016;22(34):7824-40.
Jahanbakhsh Sefidi F, Keyvani H, Monavari SH, Alavian SM, Fakhim S, Bokharaei-Salim F. Distribution of hepatitis C virus genotypes in Iranian chronic infected patients. Hepatitis Monthly. 2013;13(1):e7991.
Khodabandehloo M, Roshani D. Prevalence of hepatitis C virus genotypes in Iranian patients: a systematic review and meta-analysis. Hepatitis Monthly. 2014;14(12):e22915.
Sadeghi F, Salehi-Vaziri M, Almasi-Hashiani A, Gholami-Fesharaki M, Pakzad R, Alavian SM. Prevalence of Hepatitis C Virus Genotypes Among Patients in Countries of the Eastern Mediterranean Regional Office of WHO (EMRO): A Systematic Review and Meta-Analysis. Hepatitis Monthly. 2016;16(4):e35558.
Keyvani H, Alizadeh AH, Alavian SM, Ranjbar M, Hatami S. Distribution frequency of hepatitis C virus genotypes in 2231 patients in Iran. Hepatology Research. 2007;37(2):101-3.
Samimi-Rad K, Rahimnia R, Sadeghi M, Malekpour SA, Marzban M, Keshvari M, et al. Epidemic History of Hepatitis C Virus among Patients with Inherited Bleeding Disorders in Iran. PloS One. 2016;11(9):e0162492.
Keshvari M, Alavian S, Behnava B, Miri S, Tabatabaei S, Abolghasemi H, et al. Distribution of hepatitis C virus genotypes in iranian patients with congenital bleeding disorders. Iranian Red Crescent Medical Journal. 2010;2010(6):608-14.
Ahmadi Ghezeldasht S, Hedayati-Moghaddam MR, Shamsian K, Fathimoghadam F, Bidkhori HR, Rezaee SA. Prevalence of Hepatitis C Virus Infection in General Population of Mashhad, Northeastern Iran. Iranian Journal of Public Health. 2017;46(3):408-13.
Vossughinia H, Goshayeshi L, Bayegi HR, Sima H, Kazemi A, Erfani S, et al. Prevalence of hepatitis C virus genotypes in mashhad, northeast iran. Iranian Journal of Public Health. 2012;41(9):56-61.
Alavian SM. Hepatitis C infection in Iran; A review article. Iranian Journal of Clinical Infectious Diseases. 2009;4(1):47-59.
World Health Organization. Global health sector strategy on viral hepatitis 2016–2021; Towards ending viral hepatitis. Geneva: World Health Organization; 2016. Available from: https://www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/.
World Health Organization. Guidelines for the screening care and treatment of persons with chronic hepatitis C infection. Geneva: World Health Organization; 2016.
Assarehzadegan MA, Ghafourian Boroujerdnia M, Zandian K. Prevalence of hepatitis B and C infections and HCV genotypes among haemophilia patients in ahvaz, southwest iran. Iranian Red Crescent Medical Journal. 2012;14(8):470-4.
Rafiei A, Darzyani AM, Taheri S, Haghshenas MR, Hosseinian A, Makhlough A. Genetic diversity of HCV among various high risk populations (IDAs, thalassemia, hemophilia, HD patients) in Iran. Asian Pacific Journal of Tropical Medicine. 2013;6(7):556-60.
Ziyaeyan M, Alborzi A, Jamalidoust M, Badiee P, Moeini M, Kadivar A. Prevalence of hepatitis C virus genotypes in chronic infected patients, southern Iran. Jundishapur Journal of Microbiology. 2011;4(3):141-6.
Asif N, Zafar T, Hassan K, Naseem L. Seroprevalence Anti HCV Antibodies, HCV- RNA and its Genotypes among Patients of Hemophilia, at Hemophilia Treatment Centre Pakistan Institute of Medical Sciences, Islamabad. International Journal of Pathology. 2009;7(2):84-7.
Al-Kubaisy WA, Al-Naib KT, Habib MA. Prevalence of HCV/HIV co-infection among haemophilia patients in Baghdad. Eastern Mediterranean Health Journal. 2006;12(3-4):264-9.
Awidi A, Arikat M, Kailani M, Anshasi B, Barqawi M, Dwairi M, et al. Hemophilia in Jordan: Study of inhibitors and viral status. Jordan Medical Journal. 2006:14-20.
Ramia S, Klayme S, Naman R. Infection with hepatitis B and C viruses and human retroviruses (HTLV-I and HIV) among high-risk Lebanese patients. Annals of Tropical Medicine and Parasitology. 2003;97(2):187-92.
- Abstract Viewed: 191 times
- PDF Downloaded: 85 times